« Back to Record
Citation APA

de Azambuja, E., Lemort, M., Rossari, J., Moulin, C., Buttice, A., D'Agostini, G., D'Hondt, V., Lebrun, F., Lalami, Y., Cardoso, F., Sotiriou, C., Gil, T., De Vriendt, D., Marinus, W., Paesmans, M., Piccart-Gebhart, M., & Awada, A. (2011). Phase I study of lapatinib (L) and temozolomide (T) combination for the treatment of progressive brain metastases (BM) in HER2-positive metastatic breast cancer patients (Pts) (LAPTEM, LAP 111172). Poster session presented at ASCO Annual Meeting (2011-06: Chicago, USA).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/244761

de Azambuja, E., Lemort, M., Rossari, J., Moulin, C., Buttice, A., D'Agostini, G., D'Hondt, V., Lebrun, F., Lalami, Y., Cardoso, F., Sotiriou, C., Gil, T., De Vriendt, D., Marinus, W., Paesmans, M., Piccart-Gebhart, M., & Awada, A. (2011). Phase I study of lapatinib (L) and temozolomide (T) combination for the treatment of progressive brain metastases (BM) in HER2-positive metastatic breast cancer patients (Pts) (LAPTEM, LAP 111172). Poster session presented at ASCO Annual Meeting (2011-06: Chicago, USA).